Athena Global Technologies Declares Q1 FY27 Un-audited Results
Athena Global Technologies Limited announced the outcome of its Board Meeting held on August 14, 2026. The board approved the standalone and consolidated un-audited financial results for the first quarter ended June 30, 2026, along with the limited review report. Key decisions included approving an increase in investment limit in Optionally Convertible Debentures (OCDs) of Medley Medical Solutions Private Limited and Tutoroot Technologies Private Limited to an aggregate of up to ₹50 crore. The company also approved the Director's Report for FY26 and resolved to hold its 34th Annual General Meeting (AGM) on September 30, 2026, through video conference. The record date for the AGM was also considered.
Key Highlights
- Approved standalone & consolidated un-audited financial results for Q1 FY27.
- Increased investment limit in OCDs of two subsidiaries to ₹50 crore.
- Resolved to hold the 34th AGM on September 30, 2026.
- Approved Director's Report for the financial year ended March 31, 2026.
- Considered and fixed record date for the 34th AGM.
Price Impact
More from ATHENAGLO